|Bid||0.00000 x 0|
|Ask||0.00000 x 0|
|Day's Range||9.07 - 9.77|
|52 Week Range||4.35 - 11.97|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||68.59|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CORAL GABLES, FL / ACCESSWIRE / February 21, 2019 / The 2019 year has already shown a significant amount of upward momentum for the marijuana stock market. A key reason for this tidal shift of positive energy is due to the fact that companies throughout the industry are progressing because many states in the U.S., as well as Canada, have passed legislation in favor of legalizing cannabis. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Emerald Health Therapeutics Inc (EMHTF) (TSX-VEMH), CannTrust Holdings Inc (OTC PINK: CNTTF), and KushCo Holdings Inc (KSHB) are 4 pot stocks that could test this week's highs.
Why CannTrust Is Trending Higher in February(Continued from Prior Part)CannTrust’s valuationsCannabis stocks (HMMJ) experienced a steep sell-off in December along with the broader markets. This sell-off led to the companies in the cannabis sector
Why CannTrust Is Trending Higher in February(Continued from Prior Part)Analyst ratingsEarlier in this series, we discussed how CannTrust (CNTTF) has performed so far this year in 2019. The stock is all set to up-list on the New York Stock Exchange
Why CannTrust Is Trending Higher in FebruaryCannTrust’s gainsCannTrust (CNTTF) has been trending higher ever since the beginning of this year. The stock has returned nearly 75% YTD as of February 20. In February alone, the company returned about
The fact is that the marijuana industry is still very much in its infancy because, until recently, society had historically been vehemently opposed to cannabis. If this continues, the cannabis industry may see an increase in investor attention in the near future. Premier Health Group (OTC:PHGRF) (CSE:PHGI), Village Farms International Inc (VFFIF), CannTrust Holdings Inc (OTC PINK: CNTTF), and Aurora Cannabis Inc (NYSE: ACB, TSX: ACB) are four pot stocks that could test this week's highs.
On Jan. 8, the Canada-based producer of cannabis said it applied to list its stock on the NYSE and filed a registration statement on Form 40-F with the US Securities and Exchange Commission. It will also continue to list its shares on the Toronto Stock Exchange.
Canadian cannabis company CannTrust Holdings Inc. said Wednesday it has met the requirements for a listing on the New York Stock Exchange and will begin trading there on Feb. 25. The Vaughan, Ontario-based company will trade under the ticker symbol "CTST" and will continue with its original listing on the Toronto Stock Exchange. "We have taken steps to strengthen our management team to accelerate our growth as we face high demand for our products and expertise, both domestically and internationally," Chief Executive Peter Aceto said in a statement. The company said last week it has hired Greg Guyatt as chief financial officer. Guyatt was previously CFO of GreenSpace Brands, a natural food product company, and has also done stints at Deloitte and worked in capital markets. Toronto-listed shares of CannTrust have gained 74% in 2019 so far, while the S&P 500 has gained 11%.
VAUGHAN, ON , Feb. 20, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST) is pleased to announce that it has satisfied all the regulatory requirements to list its common shares on the New York Stock Exchange ("NYSE"). Trading of the Company's common shares on the NYSE will begin on Monday, February 25, 2019 under the ticker symbol "CTST". The Company's common shares will continue to be listed on the Toronto Stock Exchange under the ticker symbol "TRST".
Rounding Up Cannabis-Sector Stocks: Mixed PerformanceCannabis stocks mixedOn February 15, the cannabis sector was broadly mixed with some in the positive territory and some in the negative territory.Canopy Growth (WEED)(CGC) saw the biggest loss
Although cannabis remains federally criminalized, if more US states follow in California's footsteps, this may result in an influx of investors looking to the marijuana stock market for opportunities. Nabis Holdings (INNPF) (NAB), INSYS Therapeutics Inc (INSY), CannTrust Holdings Inc (OTC PINK: CNTTF), and Canopy Rivers Inc (OTC PINK: CNPOF) (RIV.V) are four cannabis companies picking up speed on Tuesday. Nabis Holdings (INNPF) (NAB) is a Canadian investment company focused on investing in high-quality cash flowing and strategic assets across multiple aspects of the cannabis sector primarily in the U.S. limited license states with a roadmap to expand globally.
Analysts' Ratings for WEED, TLRY, and APHA in February(Continued from Prior Part)Aphria Aphria (APHA) reported its earnings on January 11. Since then, the stock has risen nearly 30% as of February 12. Aphria has made a significant recovery since it
VAUGHAN, ON , Feb. 13, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST) is pleased to announce that it has appointed Greg Guyatt , CPA CA as Chief Financial Officer ("CFO") effective February 19, 2019 , further strengthening the Company's leadership team. Greg comes to CannTrust from GreenSpace Brands Inc. (JTR.V), a Canadian-based premium natural food product company, where he served as CFO. Greg began his career with Deloitte.
Leafbuyer Technologies Inc (OTC:LBUY), Tilray Inc (TLRY), CannTrust Holdings Inc (OTC PINK: CNTTF), and Aurora Cannabis Inc (ACB) are 4 pot stocks worth looking into on Tuesday. The Company, through its subsidiary, LB Media Group LLC, operates an online platform for trending cannabis deals and specials and has been lauded as the most comprehensive source for ascertaining cannabis-related information. Leafbuyer Technologies Inc (OTC:LBUY) today announced that the Company has expanded its operations into the emerging Oklahoma medical cannabis market.
High-growth stocks draw the lion's share of the attention in financial media. These securities usually show higher levels of volatility and often represent the future of the American economy. Today, these equities often revolve around new technologies like AI, VR and the Internet of Things (IoT).However, concepts that we might consider "new again" also draw this interest. Due to decades of suppression, cannabis has become one of these areas. Also, judging by the performance of Chipotle (NYSE:CMG), even equities revolving around fast food can turn into high-growth stocks with the right approach. * 10 Best Dividend Stocks to Buy for the Next 10 Months As one might expect, the overwhelming majority of these stocks carry the high P/E ratio that goes along with elevated growth. However, not all prospective buyers want that level of risk. Fortunately, a few high-growth stocks also fall into the "undervalued stocks" category. The following equities constitute some of the best stocks for combining growth with value:InvestorPlace - Stock Market News, Stock Advice & Trading TipsSource: Shutterstock AbbVie (ABBV)Drug equities don't often make lists of high-growth stocks. AbbVie (NYSE:ABBV) formed in 2013 when it split from Abbott Laboratories (NYSE:ABT). It constitutes what was once Abbott's pharma division.ABBV stock has suffered in recent months as its old blockbuster drug, Humira, faces patent expirations in many countries. However, AbbVie's drug pipeline has received favorable reviews. For this reason, most analysts believe that a new drug or a combination of future best sellers will more than replace the income lost from generic versions of Humira.Still, due to the uncertainty, ABBV stock trades at only 8.4 times forward earnings. However, even with a single-digit P/E ratio, Wall Street predicts 10.6% profit growth for 2019. They also believe the average increase will come in at almost 13.4% per year over the next five years.ABBV also offers one key benefit stemming from its former association with Abbott -- dividend aristocrat status. Walking away from its 46-year streak of payout hikes would put ABBV stock at risk. Hence, one can assume the increases will continue. Their board also approved a 40% increase in 2018 and a 19% hike for this year. Given the pressure to raise dividend payments every year, this is a remarkable show of confidence. Moreover, thanks to a lower stock price and higher dividends, the yield now stands at 5.4%.Investing in ABBV stock now involves some faith. However, with a single-digit P/E, double-digit profit growth, and a generous, growing dividend, investors could receive tremendous rewards for believing.Source: Apple Apple (AAPL)With its $800 billion market cap and massive slide last fall, Apple (NASDAQ:AAPL) might seem like a strange choice for a high-growth stocks list. Indeed, both the stock and the earnings projection saw a considerable move lower as iPhone sales fell well short of initial estimates. Also, laws of mathematics weigh on growth. An increase in AAPL's market cap of just 10% would mean $80 billion in growth, eight times the minimum size of a large-cap stock.However, as smartphone prices fall, Apple is working to make itself less iPhone-dependent. It no longer reports iPhone unit sales. Moreover, moves into services and healthcare should bring new sources of revenue.Due to tepid iPhone sales, profit growth for the year will come in at only 0.3%. But it should reclaim its high-growth status assuming the predicted 11.5% growth (and higher in the years after) comes to pass. * 7 Bank Stocks to Buy After the BB&T-Suntrust Mega-Merger AAPL stock may suffer for a time as it works to diversify sales away from the iPhone. However, with its enormous cash hoard and its ability to pioneer new technologies, AAPL stock will remain a solid growth story as it works to reclaim its $1 trillion market cap.Source: Shutterstock CannTrust (CNTTF)I normally would not place an equity with a 51.5 trailing P/E ratio in the "cheap" category, but compared to peers in the cannabis space, CannTrust (OTCMKTS:CNTTF) remains inexpensive. Although one can place almost every marijuana equity in the "high-growth stocks" category right now, CannTrust stands out with its consistent profitability.For those concerned about the OTC listing, CannTrust applied to trade on the NYSE last month. Once that listing occurs, more traders can buy it, so it should see some increase at that time.As most know, the Canadian marijuana boom came to an abrupt end in October when the product gained full legal status in Canada. However, legalization of one form of cannabis, hemp, has reignited this boom south of the Canadian border. The equities of larger peers such as Canopy Growth (NYSE:CGC) have already recovered most of the losses which occurred following legalization in Canada. CNTTF stock has also risen by more than 60% from its December low.Even if full legal status does not come soon, both hemp and CBD-related products alone should allow for massive growth across the U.S. With its specialty in cannabis oils, CannTrust should benefit. The company also expanded into Europe by becoming the first and only foreign seller of cannabis oil in Denmark beginning in October.At this moment, most cannabis equities could be described as high-growth stocks. However, with its relatively low P/E, its focus on cannabis oil, and the move to the NYSE, CannTrust delivers this growth at a lower risk compared with its key peers.Source: Qualcomm Qualcomm (QCOM)Qualcomm (NASDAQ:QCOM) stock has suffered in recent years. A long-running legal dispute with Apple has resulted in the exclusion of Qualcomm chips from the later models of the iPhone. This and other legal battles regarding its licensing practices have weighted on QCOM. As a result, the stock trades nearly 40% below a multi-year high last seen in 2014.However, a great deal of anticipation surrounds its 5G-capable Snapdragon 855 chip. Carriers have begun to launch 5G networks, and most expect 5G capable phones to see a wide release beginning later this year. While QCOM's chip will not appear in the iPhone, makers of Android-powered smartphones have shown an interest. As a result, analysts believe that profit increases will again see double-digit increases beginning in 2020. After years of profit declines, Wall Street predicts that annual growth will average 10.7% per year over the next five years. This will occur just as the company's forward P/E ratio falls to around 11.6.QCOM stock has also quietly developed a reputation as a dividend-paying stock. Despite declining profits in past years, Qualcomm has hiked its payout for eight years in a row. As a result of the increases and the lower stock price, the dividend yield has risen to about 4.9%. * 7 Breakout Stocks In Early 2019 Yes, its dispute with Apple has weighed on the stock. However, thanks to 5G, the company has developed a new source of revenue. Investors can also collect a generous dividend while waiting for 5G to revive QCOM. Thanks to that dividend, QCOM stock should pay off even if it does not pay off in growth.Source: Shutterstock Spirit (SAVE)Spirit (NYSE:SAVE) has offered value and growth to an industry not known for fostering high-growth stocks: airlines. For decades, Southwest (NYSE:LUV) brought innovation to the industry as its take on air travel brought lower fares, profits, and high-growth to a stagnant, unprofitable industry.Today, Spirit leads that charge. As the leader of the ultra-low-fare segment of the industry, it continues to see massive profit growth and expansion in both domestic and international markets. Spirit has won over price-sensitive customers who will trade perks such as in-flight beverages and carry-on bags for lower costs.Like Southwest, Spirit has depended on one plane type. However, the company now plans to add a type of regional jet to its fleet. This will allow SAVE to bring low fares to smaller markets dominated by legacy carriers.Even without smaller markets, it has already seen growth numbers that shoot toward the stratosphere. Analysts forecast profit growth of 45.7% for 2019. They also believe earnings increases will average above 20% per year for the foreseeable future.Despite this growth, Spirit, like other airlines, has struggled to achieve higher P/E ratios. This may explain why its multiple is only slightly higher than slower-growth airlines such as American (NASDAQ:AAL) or Delta (NYSE:DAL). SAVE's forward P/E currently stands at around 9.6.Admittedly, few gravitate to airlines when looking for cheap, high-growth stocks. However, the massive profit growth and continuous expansion show that Spirit has become the king of the ultra-low-fare airline sector. Driven by small markets and foreign expansion, profits should continue to climb.As of this writing, Will Healy is long ABBV and CNTTF stock. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Fundamentally Sound Dividend Stocks to Buy * 5 Reasons Reeling FAANG Stocks Won't Deliver Big Returns * 3 Reasons Canopy Growth Could Burn You Compare Brokers The post 5 High-Growth Stocks Undervalued by the Market appeared first on InvestorPlace.
[Editor's note: This story was previously published January 2019. It has since been updated and republished to reflect changes in the stock prices.]The end of last year brought something not seen in a while--a bear market. As a result, many investors were reeling as stock prices--particularly in the tech industry--massively declined. However, when stocks decline, there is one silver lining that benefits cash-rich investors: cheap stocks.Many of the best stocks are now trading at low prices. Moreover, when companies with cheap stocks maintain or improve their growth rates, many investors often look to buy their shares. As we begin the new year, the following cheap stocks have those characteristics, leaving them well-positioned to skyrocket in the coming months and years.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Best Dividend Stocks to Buy for the Next 10 Months Source: Mike Mozart via Flickr Bank of America (BAC)More than ten years after the financial crisis, Bank of America (NYSE:BAC) is again on a list of cheap stocks. BAC has come a long way since it fell to $2.50 per share at the height of the crisis. Now, it trades at almost $29 per share. Moreover, it resumed annual increases of its dividend in 2014. Today, it returns 60 cents per share of dividends to its shareholders each year, yielding about 2.1%.However, the forward price-earnings ratio of about nine is what really makes BAC one of the best stocks. The multiple is well below the stock's five-year average of about 19.Also, companies whose stocks have single-digit PEs rarely generate double-digit profit increases, but BAC is in that category. Wall Street analysts on average expect the bank's profits to rise about 121% this year. Moreover, according to the consensus estimate, BAC's average annual profit increase over the next five years will be around 20.7%.The stock fell in 2018 amid a number of headwinds. Among these headwinds were the declining results of its investment banking unit, the negative market environment and fears of an inverted yield curve.However, amid these headwinds, Warren Buffett continues to buy BAC, indicating that the Oracle of Omaha considers it to be one of the best stocks in the market. Also, one can likely assume BAC has become his favorite bank stock. He now has a bigger position in BAC than in Wells Fargo (NYSE:WFC), which used to be his favorite bank stock. Assuming the economy doesn't nose dive, investors can, like Buffett, profit handsomely from one of the best stocks to buy in the market, BAC stock.Source: Shutterstock CannTrust (CNTTF)Although it's not among the more inexpensive stocks in the S&P 500, Canadian cannabis company CannTrust (OTCMKTS:CNTTF) makes the cheap stocks list because it's inexpensive compared to its peers in the marijuana industry. Unlike most cannabis companies, CannTrust is already profitable, and CNTTF stock has a forward price-earnings ratio of about 57. In an environment in which an industry leader, Canopy Growth (NYSE:CGC), trades at 100 times its sales, CNTTF is a screaming bargain and one of the best stocks in the market.Canadian marijuana stocks have suffered from a "sell the news" phenomenon since the companies' principal product became fully legal in their home market.However, CannTrust is poised to benefit from many trends. For one, it has applied for a listing on the New York Stock Exchange. Joining the Big Board should open up CNTTF stock to a new class of investors. Secondly, although cannabis remains on the list of Schedule 1 drugs in the U.S., the recent legislation that legalized hemp should give all Canadian marijuana firms a foothold in the U.S. market.The company's focus on pharma also provides the stock with another potential catalyst. CannTrust sent its first shipment of cannabis oil to Denmark in the third quarter of 2018. It has also entered the Asia-Pacific market, through a partnership with Australia-based Cannatrek. Consequently, even if the company fails to meaningfully penetrate the U.S. market, it still can benefit from overseas expansion.Furthermore, even though CannTrust's valuation is lower than that of its major peers, its growth should remain strong for the foreseeable future. On average, analysts predict that its profits will increase by almost 155% this year, making CNTTF a very cheap stock, despite its forward price-earnings ratio of nearly 30. As CannTrust moves into other developed countries and possibly the U.S., a revived interest in cannabis should enable its valuation to catch up with that of its peers.Source: Shutterstock Intel (INTC)Few PC-era stocks have suffered as much as Intel (NASDAQ:INTC) has. Once the world's largest chip maker, Intel stagnated as consumers increasingly turned away from PCs. Intel's PC-era peers such as Microsoft (NASDAQ:MSFT), Nvidia (NASDAQ:NVDA), and even AMD (NASDAQ:AMD) built new business lines and resumed growing. However, INTC stock continued to languish. The high turnover of its top management, as well as security-related issues, also weighed on Intel stock.However, INTC looks ready to again become one of the best stocks to buy in tech. The company has invested heavily in data-center technology. As a result, its Data Center group appears poised to overtake its PC Client group in size over the next few years.Due to Intel's purchase of Mobileye, INTC has become a leader in the autonomous-vehicle market. That, along with the company's Internet of Things (IoT) products, should help INTC stock rise. And as the advent of 5G makes more advanced applications possible, Intel will benefit even more from these trends.INTC is a cheap stock due to its price-earnings multiple. It trades at a forward PE ratio of about 10.6, showing that investors have yet to fully appreciate Intel's comeback.Due to a temporary glut of chips, Intel 's profit growth will be slow this year. However, its profits should resume growing by double-digit percentage rates in 2020. Once investors begin to realize that Intel has resumed a leadership role in the tech industry making it one of the best stocks in the market, it should again command valuations comparable to its peers in big tech.As of this writing, Will Healy is long CNTTF. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Fundamentally Sound Dividend Stocks to Buy * 5 Reasons Reeling FAANG Stocks Won't Deliver Big Returns * 3 Reasons Canopy Growth Could Burn You Compare Brokers The post 3 Cheap Stocks to Buy (Before They Skyrocket) appeared first on InvestorPlace.
Do Cannabis Stocks Look Expensive?(Continued from Prior Part)Other cannabis companies Previously in this series, we compared four cannabis stocks’ forward EV-to-sales multiples. In this part, we’ll discuss the other five cannabis stocks.
Premier Health Group (OTC:PHGRF) (CSE:PHGI), CannTrust Holdings Inc (OTC PINK: CNTTF), Canopy Growth Corp (CGC) (WEED.TO), and Tilray Inc (TLRY) represent four pot stocks that could set the standard on Thursday. The Company has made great strides over the last few months, as its executive leadership has insisted on investing in acquisitions and products meant to demonstrate to consumers that Premier has its eyes on the future. Premier Health Group (OTC:PHGRF) (CSE:PHGI) today announced that the Company is now formally entering the cannabis clinic space.
Curaleaf Is Up ~40% in 2019: Is There More Upside?(Continued from Prior Part)Current operations Curaleaf Holdings (CURA) (CURLF) is a vertically integrated cannabis company headquartered in Wakefield, Massachusetts. The company’s footprint spans
Why Analysts Expect Tilray to Report a Loss in the Fourth Quarter(Continued from Prior Part)Margins In this part, we’ll look at analysts’ estimates for Tilray’s (TLRY) gross margin. Cannabis companies must mitigate pressure on margins as a
What's Driving the Recent Gains in Cronos Group?(Continued from Prior Part)Altria’s deep pockets In the earlier part of this series, we discussed how picking the cannabis companies that will ride the cannabis boom opportunity successfully will
Canopy Growth's Bruce Linton Talks Next Steps for the IndustryShedding lightLast week, Canopy Growth (WEED) (CGC) CEO Bruce Linton shed light on the next phases for the cannabis industry at the Cantech Investment Conference.These insights have